Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Item Type
Advanced Search
Help
About DSpace
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Saved Searches
Favorites
Repository of UOI "Olympias"
Repository of OAI
Browsing by Author Wanders, J.
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Jump to:
Α
Β
Γ
Δ
Ε
Ζ
Η
Θ
Ι
Κ
Λ
Μ
Ν
Ξ
Ο
Π
Ρ
Σ
Τ
Υ
Φ
Χ
Ψ
Ω
or enter first few letters:
View Option
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 5 to 12 of 12
< previous
Title
Author(s)
Issue date
???itemlist.???
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
Briasoulis, E.
;
Judson, I.
;
Pavlidis, N.
;
Beale, P.
;
Wanders, J.
;
Groot, Y.
;
Veerman, G.
;
Schuessler, M.
;
Niebch, G.
;
Siamopoulos, K.
;
Tzamakou, E.
;
Rammou, D.
;
Wolf, L.
;
Walker, R.
;
Hanauske, A.
24-Nov-2015
-
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group
Hanauske, A. R.
;
Catimel, G.
;
Aamdal, S.
;
ten Bokkel Huinink, W.
;
Paridaens, R.
;
Pavlidis, N.
;
Kaye, S. B.
;
te Velde, A.
;
Wanders, J.
;
Verweij, J.
24-Nov-2015
-
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group
Verweij, J.
;
Wanders, J.
;
Nielsen, A. L.
;
Pavlidis, N.
;
Calabresi, F.
;
ten Bokkel Huinink, W.
;
Bruntsch, U.
;
Piccart, M.
;
Franklin, H.
;
Kaye, S. B.
24-Nov-2015
-
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer
Kerbrat, P.
;
Dieras, V.
;
Pavlidis, N.
;
Ravaud, A.
;
Wanders, J.
;
Fumoleau, P.
24-Nov-2015
-
Phase II trial with S-1 in chemotherapy-naive patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG)
Chollet, P.
;
Schoffski, P.
;
Weigang-Kohler, K.
;
Schellens, J. H.
;
Cure, H.
;
Pavlidis, N.
;
Grunwald, V.
;
De Boer, R.
;
Wanders, J.
;
Fumoleau, P.
24-Nov-2015
-
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies
Schellens, J. H.
;
Heinrich, B.
;
Lehnert, M.
;
Gore, M. E.
;
Kaye, S. B.
;
Dombernowsky, P.
;
Paridaens, R.
;
van Oosterom, A. T.
;
Verweij, J.
;
Loos, W. J.
;
Calvert, H.
;
Pavlidis, N.
;
Cortes-Funes, H.
;
Wanders, J.
;
Roelvink, M.
;
Sessa, C.
;
Selinger, K.
;
Wissel, P. S.
;
Gamucci, T.
;
Hanauske, A. R.
24-Nov-2015
-
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9
Schellens, J. H.
;
Dombernowsky, P.
;
Cassidy, J.
;
Epelbaum, R.
;
Dirix, L.
;
Cox, E. H.
;
Wanders, J.
;
Calabresi, F.
;
Paridaens, R.
;
Monfardini, S.
;
Wolff, J.
;
Loos, W. J.
;
Verweij, J.
;
Pavlidis, N.
;
Hanauske, A. R.
24-Nov-2015
-
Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group
Kaplan, S.
;
Hanauske, A. R.
;
Pavlidis, N.
;
Bruntsch, U.
;
te Velde, A.
;
Wanders, J.
;
Heinrich, B.
;
Verweij, J.
24-Nov-2015
-